Cargando…
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison
OBJECTIVE: Del Nido (DN) cardioplegia solution provides a depolarized hyperkalemic arrest lasting up to 60 minutes, and the addition of lidocaine may limit intracellular calcium influx. Single-dose DN cardioplegia solution may offer an alternative myocardial protection strategy to multi-dose cold wh...
Autores principales: | Yerebakan, Halit, Sorabella, Robert A, Najjar, Marc, Castillero, Estibaliz, Mongero, Linda, Beck, James, Hossain, Maliha, Takayama, Hiroo, Williams, Mathew R, Naka, Yoshifumi, Argenziano, Michael, Bacha, Emile, Smith, Craig R, George, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220058/ https://www.ncbi.nlm.nih.gov/pubmed/25359427 http://dx.doi.org/10.1186/s13019-014-0141-5 |
Ejemplares similares
-
Feasibility and safety of continuous retrograde administration of Del Nido cardioplegia: a case series
por: Najjar, Marc, et al.
Publicado: (2015) -
Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp
por: D’Angelo, Alex M, et al.
Publicado: (2021) -
A novel dosing strategy of del Nido cardioplegia in aortic surgery
por: Chung, Megan M., et al.
Publicado: (2022) -
Effects of Del Nido cardioplegia on coronary bypass surgery
por: Bademci, Mehmet S, et al.
Publicado: (2022) -
Del Nido cardioplegia – what is the current evidence?
por: Sanetra, Krzysztof, et al.
Publicado: (2018)